Erratum: Mechanism of inhibition of the human sirtuin enzyme SIRT3 by nicotinamide: Computational and experimental studies (PLoS ONE (2015) 9:9 DOI:10.1371/journal.pone.0107729);Mechanism of inhibition of the human sirtuin enzyme SIRT3 by nicotinamide: Computational and experimental studies

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Guan, Xiangying ^a   Lin, Ping ^a   Knoll, Eric ^a   Chakrabarti, Raj ^a,b  

^a Division of Fundamental Research PMC Advanced Technology LLC   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN 3; LIGAND; PROTEIN BINDING; SIRT3 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; CALCULATION; COMPUTER MODEL; DEACETYLATION; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; KINETICS; LIGAND BINDING; MOLECULAR DYNAMICS; PHYSICAL CHEMISTRY; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYMOLOGY; METABOLISM; MITOCHONDRION;

HUMANS; KINETICS; LIGANDS; MITOCHONDRIA; NAD; NIACINAMIDE; PROTEIN BINDING; SIRTUIN 3;

EID: 84907145662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138393     Document Type: Erratum

References (84)

1. Minino AM, Murphy SL, Xu J, Kochanek KD (2011) Deaths: final data for 2008. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 59: 1-126.
2. Kaeberlein M, McVey M, Guarente L (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes & Development 13: 2570-2580.
3. Lin SJ, Defossez PA, Guarente L (2000) Requirement of NAD and SIR2 for lifespan extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128.
4. Frye RA (1999) Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochemical and Biophysical Research Communications 260: 273-279.
5. Frye RA (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochemical and Biophysical Research Communications 273: 793-798.
6. Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP (2002) SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proceedings of the National Academy of Sciences of the United States of America 99: 13653-13658.
7. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, et al. (2007) Mammalian sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Molecular and Cellular Biology 27: 8807-8814.
8. Hallows WC, Lee S, Denu JM (2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proceedings of the National Academy of Sciences of the United States of America 103: 10230-10235.
9. Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E (2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proceedings of the National Academy of Sciences of the United States of America 103: 10224-10229.
10. Hallows WC, Yu W, Smith BC, Devires MK, Ellinger JJ, et al. (2011) Sirt3 Promotes the Urea Cycle and Fatty Acid Oxidation during Dietary Restriction. Molecular Cell 41: 139-149.
11. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, et al. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464: 121-137.
12. Lu ZP, Bourdi M, Li JH, Aponte AM, Chen Y, et al. (2011) SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity. Embo Reports 12: 840-846.
13. Guarente L (2014) Sirtuins and the Warburg effect. Nature Medicine 20: 24-25.
14. Finley LWS, Carracedo A, Lee J, Souza A, Egia A, et al. (2011) SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1 alpha Destabilization. Cancer Cell 19: 416-428.
15. Sauve AA (2010) Sirtuin chemical mechanisms. Biochimica Et Biophysica Acta-Proteins and Proteomics 1804: 1591-1603.
16. Gomes AP, Price NL, Ling AJY, Moslehi JJ, Montgomery MK, et al. (2013) Declining NAD(+) Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging. Cell 155: 1624-1638.
17. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, et al. (2012) Age-Associated Changes In Oxidative Stress and NAD(+) Metabolism In Human Tissue. Plos One 7: e42357.
18. Berger F, Ramirez-Hernandez MH, Ziegler M (2004) The new life of a centenarian: signalling functions of NAD(P). Trends in Biochemical Sciences 29: 111-118.
19. Dietrich LS (1971) Regulation of Nicotinamide Metabolism. American Journal of Clinical Nutrition 24: 800-804.
20. Smythe GA, Braga O, Brew BJ, Grant RS, Guillemin GJ, et al. (2002) Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry. Analytical Biochemistry 301: 21-26.
21. Hagino Y, Lan SJ, Ng CY, Henderso. Lm (1968) Metabolism of Pyridium Precursors of Pyridine Nucleotides in Perfused Rat Liver. Journal of Biological Chemistry 243: 4980-4986.
22. Avalos JL, Boeke JD, Wolberger C (2004) Structural basis for the mechanism and regulation of Sir2 enzymes. Molecular Cell 13: 639-648.
23. Sauve AA, Moir RD, Schramm VL, Willis IM (2005) Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Molecular Cell 17: 595-601.
24. Sauve AA, Schramm VL (2003) Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. Biochemistry 42: 9249-9256.
25. Jin L, Galonek H, Israelian K, Choy W, Morrison M, et al. (2009) Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3. Protein Science 18: 514-525.
26. Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J Comput Chem 32: 866-877.
27. Rastelli G, Rio AD, Degliesposti G, Sgobba M (2010) Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. Journal of Computational Chemistry 31: 797-810.
28. Lyne PD, Lamb ML, Saeh JC (2006) Accurate Prediction of the Relative Potencies of Members of a Series of Kinase Inhibitors Using Molecular Docking and MM-GBSA Scoring. J Med Chem 49: 4805-4808.
29. Guimaraes CRW, Cardozo M (2008) MM-GB/SA rescoring of docking poses in structure-based lead optimization. Journal of Chemical Information and Modeling 48: 958-970.
30. Copeland RA (2005) Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. New Jersey: A John Wiley & Sons, Inc. 271 p.
31. Rye PT, Frick LE, Ozbal CC, Lamarr WA (2011) Advances in Label-Free Screening Approaches for Studying Sirtuin-Mediated Deacetylation. Journal of Biomolecular Screening 16: 1217-1226.
32. Smith DL, Li CH, Matecic M, Maqani N, Bryk M, et al. (2009) Calorie restriction effects on silencing and recombination at the yeast rDNA. Aging Cell 8: 633-642.
33. Aparicio OM, Billington BL, Gottschling DE (1991) Modifiers of Position Effect Are Shared Between Telomeric and Silent Mating-Type Loci in Saccharomyces-Cerevisiae Cell 66: 1279-1287.
34. Grubisha O, Smith BC, Denu JM (2005) Small molecule regulation of Sir2 protein deacetylases. Febs Journal 272: 4607-4616.
35. Jackson MD, Schmidt MT, Oppenheimer NJ, Denu JM (2003) Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. Journal of Biological Chemistry 278: 50985-50998.
36. Cosgrove MS, Bever K, Avalos JL, Muhammad S, Zhang XB, et al. (2006) The structural basis of sirtuin substrate affinity. Biochemistry 45: 7511-7521.
37. Jin L, Wei WT, Jiang YB, Peng H, Cai JH, et al. (2009) Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes. Journal of Biological Chemistry 284: 24394-24405.
38. Zhao X, Allison D, Condon B, Zhang FY, Gheyi T, et al. (2013) The 2.5 angstrom Crystal Structure of the SIRT1 Catalytic Domain Bound to Nicotinamide Adenine Dinucleotide (NAD(+)) and an Indole (EX527 Analogue) Reveals a Novel Mechanism of Histone Deacetylase Inhibition. Journal of Medicinal Chemistry 56: 963-969.
39. Davenport AM, Huber FM, Hoelz A (2014) Structural and functional analysis of human SIRT1. J Mol Biol 426: 526-541.
40. Avalos JL, Bever KM, Wolberger C (2005) Mechanism of sirtuin inhibition by nicotinamide: Altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Molecular Cell 17: 855-868.
41. North BJV, E. (2004) Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biology 5: 224.
42. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1. Journal of Biological Chemistry 277: 45099-45107.
43. Giralt A, Villarroya F (2012) SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochemical Journal 444: 1-10.
44. Imai S, Yoshino J (2013) The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obesity & Metabolism 15: 26-33.
45. Yang HY, Yang T, Baur JA, Perez E, Matsui T, et al. (2007) Nutrient-sensitive mitochondrial NAD(+) levels dictate cell survival. Cell 130: 1095-1107.
46. Schmidt MT, Smith BC, Jackson MD, Denu JM (2004) Coenzyme specificity of Sir2 protein deacetylases - Implications for physiological regulation. Journal of Biological Chemistry 279: 40122-40129.
47. Tervo AJ, Kyrylenko S, Niskanen P, Salminen A, Leppanen J, et al. (2004) An in silico approach to discovering novel inhibitors of human sirtuin type 2. Journal of Medicinal Chemistry 47: 6292-6298.
48. Fischer F, Gertz M, Suenkel B, Lakshminarasimhan M, Schutkowski M, et al. (2012) Sirt5 Deacylation Activities Show Differential Sensitivities to Nicotinamide Inhibition. Plos One 7: e45098.
49. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Sinclair DA (2003) Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423: 181-185.
50. Adams JD, Klaidman LK (2007) Sirtuins, nicotinamide and aging: A critical review. Letters in Drug Design & Discovery 4: 44-48.
51. Qin WP, Yang TL, Ho L, Zhao Z, Wang J, et al. (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. Journal of Biological Chemistry 281: 21745-21754.
52. Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, et al. (2012) The NAD(+) Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity. Cell Metabolism 15: 838-847.
53. Segel IH (1993) Enzyme Kinetics Behavior and analysis of rapid equilibrium and steady-state enzyme systems. USA: Wiley Classics Library. 957 p.
54. Gertz M, Fischer F, Nguyen GTT, Lakshminarasimhan M, Schutkowski M, et al. (2013) Ex-527 inhibits Sirtuins by exploiting their unique NAD(+)- dependent deacetylation mechanism. Proceedings of the National Academy of Sciences of the United States of America 110: E2772-E2781.
55. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, et al. (2005) Substrate-specific activation of sirtuins by resveratrol. Journal of Biological Chemistry 280: 17038-17045.
56. Shi YW, Zhou YZ, Wang SL, Zhang YK (2013) Sirtuin Deacetylation Mechanism and Catalytic Role of the Dynamic Cofactor Binding Loop. Journal of Physical Chemistry Letters 4: 491-495.
57. Hu P, Wang SL, Zhang YK (2008) Highly Dissociative and Concerted Mechanism for the Nicotinamide Cleavage Reaction in Sir2Tm Enzyme Suggested by Ab Initio QM/MM Molecular Dynamics Simulations. Journal of the American Chemical Society 130: 16721-16728.
58. Liang ZJ, Shi T, Ouyang SS, Li HL, Yu KQ, et al. (2010) Investigation of the Catalytic Mechanism of Sir2 Enzyme with QM/MM Approach: SN1 vs SN2? Journal of Physical Chemistry B 114: 11927-11933.
59. Cer RZ, Mudunuri U, Stephens R, Lebeda FJ (2009) IC50-to-K-i: a web-based tool for converting IC50 to K-i values for inhibitors of enzyme activity and ligand binding. Nucleic Acids Research 37: W441-W445.
60. Rastelli G, Del Rio A, Degliesposti G, Sgobba M (2010) Fast and Accurate Predictions of Binding Free Energies Using MM-PBSA and MM-GBSA. Journal of Computational Chemistry 31: 797-810.
61. Aqvist J, Luzhkov VB, Brandsdal BO (2002) Ligand binding affinities from MD simulations. Accounts of Chemical Research 35: 358-365.
62. Feldman JL, Baeza J, Denu JM (2013) Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins. Journal of Biological Chemistry 288: 31350-31356.
63. Hubbard BP, Gomes AP, Dai H, Li J, Case AW, et al. (2013) Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators. Science 339: 1216-1219.
64. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-716.
65. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196.
66. Cen Y, Youn DY, Sauve AA (2011) Advances in Characterization of Human Sirtuin Isoforms: Chemistries, Targets and Therapeutic Applications. Current Medicinal Chemistry 18: 1919-1935.
67. Chakrabarti R, Klibanov AM, Friesner RA (2005) Sequence optimization and designability of enzyme active sites. Proceedings of the National Academy of Sciences of the United States of America 102: 12035-12040.
68. Chakrabarti R, Klibanov AM, Friesner RA (2005) Computational prediction of native protein-ligand binding and enzyme active site sequences. Proceedings of the National Academy of Sciences of the United States of America 102: 10153-10158.
69. Bradford MM (1976) Rapid and Sensitive Method for Quantitation of Microgram Quantities of Protein Utilizing Principle of Protein-Dye Binding. Analytical Biochemistry 72: 248-254.
70. Napper AD, Hixon J, McDonagh T, Keavey K, Pons JF, et al. (2005) Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. Journal of Medicinal Chemistry 48: 8045-8054.
71. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, et al. (2010) SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1. Journal of Biological Chemistry 285: 8340-8351.
72. Hubbard BP, Gomes AP, Dai H, Li J, Case AW, et al. (2013) Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators. Science 339: 1216-1219.
73. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, et al. (2006) Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins-Structure Function and Bioinformatics 65: 712-725.
74. Wang JM, Cieplak P, Kollman PA (2000) How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? Journal of Computational Chemistry 21: 1049-1074.
75. Lu Q, Tan YH, Luo R (2007) Molecular dynamics simulations of p53 DNAbinding domain. Journal of Physical Chemistry B 111: 11538-11545.
76. Walker RC, de Souza MM, Mercer IP, Gould IR, Klug DR (2002) Large and fast relaxations inside a protein: Calculation and measurement of reorganization energies in alcohol dehydrogenase. Journal of Physical Chemistry B 106: 11658-11665.
77. Pavelites JJ, Gao JL, Bash PA, Mackerell AD (1997) A molecular mechanics force field for NAD(+), NADH, and the pyrophosphate groups of nucleotides. Journal of Computational Chemistry 18: 221-239.
78. Papamokos GV, Tziatzos G, Papageorgiou DG, Georgatos SD, Politou AS, et al. (2012) Structural Role of RKS Motifs in Chromatin Interactions: A Molecular Dynamics Study of HP1 Bound to a Variably Modified Histone Tail. Biophysical Journal 102: 1926-1933.
79. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, et al. (2005) Scalable molecular dynamics with NAMD. Journal of Computational Chemistry 26: 1781-1802.
80. Darden T, York D, Pedersen L (1993) Particle mesh Ewald - An N.log(N) method for Ewald sums in large systems. Journal of Chemical Physics 98: 10089-10092.
81. Ryckaert JP, Ciccotti G, Berendsen HJC (1977) Numerical integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes. Journal of Computational Physics 23: 327-341.
82. Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, et al. (2012) MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. Journal of Chemical Theory and Computation 8: 3314-3321.
83. Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins-Structure Function and Bioinformatics 55: 383-394.
84. Weiser J, Shenkin PS, Still WC (1999) Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). Journal of Computational Chemistry 20: 217-230.